Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-Current Assets (2020 - 2023)

Historic Non-Current Assets for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $1.2 million.

  • Terns Pharmaceuticals' Non-Current Assets fell 3987.31% to $1.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $6.1 million, marking a year-over-year decrease of 2410.69%. This contributed to the annual value of $1.8 million for FY2022, which is 6149.12% up from last year.
  • As of Q3 2023, Terns Pharmaceuticals' Non-Current Assets stood at $1.2 million, which was down 3987.31% from $1.4 million recorded in Q2 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Non-Current Assets peaked at $2.6 million during Q1 2022, and registered a low of $1.1 million during Q3 2021.
  • Over the past 4 years, Terns Pharmaceuticals' median Non-Current Assets value was $1.4 million (recorded in 2020), while the average stood at $1.6 million.
  • In the last 5 years, Terns Pharmaceuticals' Non-Current Assets skyrocketed by 11334.45% in 2022 and then crashed by 3987.31% in 2023.
  • Terns Pharmaceuticals' Non-Current Assets (Quarter) stood at $1.4 million in 2020, then decreased by 19.77% to $1.1 million in 2021, then soared by 61.49% to $1.8 million in 2022, then crashed by 33.08% to $1.2 million in 2023.
  • Its last three reported values are $1.2 million in Q3 2023, $1.4 million for Q2 2023, and $1.6 million during Q1 2023.